Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Gencom Pharmaceutical Technology is a China-based contract research and manufacturing organization (CRO/CDMO) that specializes in the development of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Founded in 2010 and headquartered in the Tianjin Economic-Technological Development Area (TEDA), the company provides custom synthesis and process optimization services for small molecule drug candidates. Their expertise spans a wide range of chemical transformations, including chiral synthesis and complex multi-step organic reactions. Tianjin Gencom serves a global clientele, supporting drug discovery and development programs from the laboratory scale through to commercial production. The company operates modern R&D laboratories and manufacturing facilities that adhere to international quality standards. It is recognized for its commitment to quality and its ability to handle challenging chemical syntheses for the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Gencom.